Access to Affordable Medicines?

The Case of CAFTA in Guatemala

You are invited to the release of the new study in Health Affairs which for the first time documents the effects of the Central-America-Dominican Republic-U.S. Free Trade Agreement (CAFTA-DR) on access to medicines.  A light lunch will be served.

Wednesday, August 26, Noon- 2:00 pm

University of California DC Washington Center,

1608 Rhode Island Ave. NW

Does CAFTA affect access to affordable life-saving medicines in Guatemala?

  How are CAFTA trade rules affecting access to low-cost generics to treat HIV/AIDS and other major diseases?

  Can trade rules affect drug  affordability in the U.S.?

 What does this mean for the future of U.S. trade policy?

        Join:

Ellen R. Shaffer, PhD MPH

and

Joe Brenner, MA

Co-Directors, Center for Policy Analysis on Trade and Health (CPATH)

Please RSVP, acceptances only, to Joseph R. McGhee at the IGCC Washington office: Phone (202) 974-6295; Fax (202) 974-6299; email:  joseph.mcghee@ucdc.edu .  For more on IGCC, see http://www-igcc.ucsd.edu.